Convergence Investment Partners’s HCA Healthcare HCA Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q2 | – | Sell |
-428
| Closed | -$202K | – | 264 |
|
|
2026
Q1 | $202K | Sell |
428
-2,526
| -86% | -$1.27M | 0.03% | 233 |
|
|
2025
Q4 | $1.38M | Buy |
2,954
+2,345
| +385% | +$1.09M | 0.27% | 131 |
|
|
2025
Q3 | $259K | Sell |
609
-80
| -12% | -$31K | 0.06% | 233 |
|
|
2025
Q2 | $264K | Sell |
689
-47
| -6% | -$16.9K | 0.07% | 215 |
|
|
2025
Q1 | $254K | Sell |
736
-108
| -13% | -$34.7K | 0.07% | 222 |
|
|
2024
Q4 | $253K | Sell |
844
-7
| -0.8% | -$2.45K | 0.06% | 223 |
|
|
2024
Q3 | $346K | Sell |
851
-41
| -5% | -$15K | 0.09% | 196 |
|
|
2024
Q2 | $287K | Sell |
892
-26
| -3% | -$8.45K | 0.08% | 214 |
|
|
2024
Q1 | $306K | Sell |
918
-4
| -0.4% | -$1.22K | 0.12% | 195 |
|
|
2023
Q4 | $250K | Sell |
922
-6
| -0.6% | -$1.48K | 0.13% | 158 |
|
|
2023
Q3 | $228K | Buy |
928
+3
| +0.3% | +$821 | 0.13% | 137 |
|
|
2023
Q2 | $281K | Sell |
925
-65
| -7% | -$18.1K | 0.16% | 128 |
|
|
2023
Q1 | $261K | Buy |
990
+30
| +3% | +$7.62K | 0.15% | 139 |
|
|
2022
Q4 | $230K | Sell |
960
-129
| -12% | -$28.9K | 0.14% | 158 |
|
|
2022
Q3 | $200K | Buy |
+1,089
| New | +$217K | 0.13% | 160 |
|
|
2022
Q2 | – | Sell |
-1,146
| Closed | -$287K | – | 230 |
|
|
2022
Q1 | $287K | Sell |
1,146
-702
| -38% | -$176K | 0.15% | 143 |
|
|
2021
Q4 | $475K | Sell |
1,848
-271
| -13% | -$66.3K | 0.24% | 101 |
|
|
2021
Q3 | $514K | Sell |
2,119
-506
| -19% | -$124K | 0.28% | 97 |
|
|
2021
Q2 | $543K | Sell |
2,625
-84
| -3% | -$17.1K | 0.23% | 103 |
|
|
2021
Q1 | $510K | Buy |
2,709
+6
| +0.2% | +$1.06K | 0.23% | 100 |
|
|
2020
Q4 | $445K | Sell |
2,703
-6,199
| -70% | -$906K | 0.22% | 107 |
|
|
2020
Q3 | $1.11M | Buy |
+8,902
| New | +$1.1M | 0.39% | 93 |
|
|
2019
Q2 | – | Sell |
-14,540
| Closed | -$1.9M | – | 340 |
|
|
2019
Q1 | $1.9M | Sell |
14,540
-1,587
| -10% | -$213K | 0.41% | 85 |
|
|
2018
Q4 | $2.01M | Buy |
16,127
+6,230
| +63% | +$836K | 0.46% | 73 |
|
|
2018
Q3 | $1.38M | Sell |
9,897
-10,198
| -51% | -$1.27M | 0.28% | 132 |
|
|
2018
Q2 | $2.06M | Buy |
20,095
+18,848
| +1,511% | +$1.91M | 0.29% | 129 |
|
|
2018
Q1 | $121K | Buy |
+1,247
| New | +$121K | 0.02% | 329 |
|
|
2016
Q4 | – | Sell |
-15,642
| Closed | -$1.18M | – | 344 |
|
|
2016
Q3 | $1.18M | Buy |
+15,642
| New | +$1.2M | 0.17% | 219 |
|
|
2015
Q1 | – | Sell |
-26,269
| Closed | -$1.93M | – | 384 |
|
|
2014
Q4 | $1.93M | Buy |
+26,269
| New | +$1.85M | 0.26% | 143 |
|
Other funds holding HCA
Convergence Investment Partners's HCA Position: Q2 2026 in Review
Convergence Investment Partners sold out of HCA Healthcare (HCA) in Q2 2026, closing a stake of 428 shares — an estimated $202K sold.
Convergence Investment Partners first reported a position in HCA in Q4 2014 and held it in 29 quarters. The position peaked at $2.06M in Q2 2018. 1,331 funds tracked by Wall St. Rank hold HCA as of Q2 2026.
- Convergence Investment Partners reported no remaining HCA Healthcare position as of Q2 2026 after selling out during the quarter.
- Convergence Investment Partners sold 428 HCA Healthcare shares in Q2 2026, an estimated $202K.
- Convergence Investment Partners first reported a position in HCA Healthcare in Q4 2014 and held it in 29 quarters.
- Convergence Investment Partners's HCA Healthcare position peaked at $2.06M in Q2 2018.
- 1,331 funds tracked by Wall St. Rank held HCA Healthcare as of Q2 2026.
Based on Convergence Investment Partners's 13F filing for Q2 2026, filed 31 Jul 2026.